News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Placental stem cells may protect against effects of pre-term lung disease
A team of researchers at The Ritchie Centre, Hudson Institute of Medical Research has published further evidence to support the use of stem cells derived from the placenta to protect newborn babies against the debilitating preterm lung disease, bronchopulmonary dysplasia (BPD), and its severe lifelong impacts.… Read more
-
Renowned Professor receives international title
rofessor Kate Loveland has had her honorary title of Liebig Professor with the Justus-Liebig University (JLU) renewed, highlighting the importance of her work with the German university.… Read more
-
Highly regarded reproductive specialist promoted
Highly regarded reproductive specialist on uterine receptivity and placental development, Guiying Nie (Research Group Head, Implantation and Placental Development, Centre for Reproductive Health) has been promoted to Adjunct Professor.… Read more
-
Research may lead to early detection of life-threatening pre-eclampsia
Pre-eclampsia is one of the more common complications of pregnancy. Symptoms can include high blood pressure, protein in urine and sudden excessive swelling of the face, hands and feet in the third trimester.… Read more
-
Professor Jock Findlay AO receives SSR Distinguished Service Award
Professor Jock Findlay AO has been honoured for his service and leadership in reproductive biology research with the Society for the Study of Reproduction’s (SSR) 32nd Annual Distinguished Service Award, presented at the society’s recent annual meeting in Washington, D.C.… Read more
-
‘40 weeks’: rethinking pregnancy to prevent stillbirth
New research from Hudson Institute of Medical Research and Monash University is rapidly changing the way women of different ethnic backgrounds and countries of origin are monitored in the final weeks of their pregnancy to better prevent stillbirth.… Read more
-
Precision medicine pipeline may improve drug treatment for pancreatic cancer
A team of scientists and clinicians in Clayton, Melbourne, has optimised a non-invasive technique to screen pancreatic cancer patients for responsiveness to specific drugs, and has commenced a trial with a drug currently used to treat colon cancer in the hope it may be effective in treating up to 10 per cent of pancreatic cancer patients.… Read more
-
Launch of the Gandel Genomics Centre to enable next generation health care
The new Gandel Genomics Centre, launched at Hudson Institute of Medical Research today (June 19) by Mr Frank McGuire, Parliamentary Secretary for Medical Research, will play a vital role in transforming the future of Victorian healthcare. The Gandel Genomics Centre will utilise world-leading technology capabilities at the Monash Health Translation Precinct and new scientific expertise… Read more
-
$130,000 grant to tackle the challenges of female contraceptive drug discovery
Hudson Institute of Medical Research scientists will investigate whether a menstruating species of desert rodent responds to ‘the pill’ in the same way that women do, in a project that will lay the foundation for accelerating the discovery of new safe and effective female contraceptives.… Read more
-
New research shows placental stem cells could protect against preterm brain injury
The placenta is a rich source of life for unborn babies, supplying oxygen and sustaining nutrition to the fetus via the umbilical cord.… Read more